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Q fever is a zoonosis caused by Coxiella burnetii. Infection can result in severe disease, 
however, little is known about the risk of infection in veterinarians. 
In a cross-sectional study among German veterinarians, participants provided sera and 
completed an exposure questionnaire. We investigated predictors for seropositivity using 
multivariable logistic regression modelling. 
The 424 participants’ median age was 40 (18-74) years, 276 (65%) were female. Sera of 
162 (38%) were positive for Coxiella burnetii phase II IgG antibodies (ELISA and IFAT). 
Predictors for seropositivity were occupational exposure to cattle (aOR 2.83; 95%CI 1.64-
4.87), occupational exposure to sheep (2.09; 1.22-3.58), male sex (1.9; 1.15-3.13), and 
increasing age (30-39 year-olds: 4.91, 2.00-12.04; 40-49 year-olds: 5.32, 2.12-13.33; >50 
year-olds: 6.70, 2.60-17.25; compared with <30 year-olds). When investigating 
occupational exposure to cattle and sheep in detail in a separate model, the seroprevalence 
increased with increasing numbers of cattle obstetrics performed per month and with 
increasing numbers of individual cattle treated per week. 
The high antibody prevalence implies a high lifetime-risk of Q fever in veterinarians. Cattle 
veterinarians, especially those frequently performing obstetrics, should be counselled early 
in their career on the clinical picture of Q fever and on specific risks. 
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Introduction 
Q fever is a bacterial zoonosis with worldwide distribution caused by the intracellular 
bacterium Coxiella (C.) burnetii. In humans, the clinical picture ranges from asymptomatic 
infection (60%) to severe acute disease including pneumonia, hepatitis, carditis, and 
meningoencephalitis (Hartzell et al. 2008, Maurin et al. 1999, Parker et al. 2006, Raoult et 
al. 2005). In 1-2% of acute symptomatic cases, chronic Q fever may develop as a serious 
complication (Fenollar et al. 2001, Raoult et al. 2000, Tissot-Dupont et al. 2007). 
Particularly persons with pre-existing heart valve disease, prosthetic valves or vascular 
grafts are at risk to develop chronic disease which in 60-70% of patients manifests as 
culture-negative endocarditis with a case fatality up to 50% (Brouqui et al. 1993, Fenollar 
et al. 2001, Fournier et al. 2010, Limonard et al. 2010, Million et al. 2010, Raoult et al. 
2000). 
Transmission mainly occurs through inhalation of aerosolized contaminated materials. 
Small ruminants and cattle livestock are the most common reservoir animals for C. burnetii 
in Europe. Infected animals shed the organism in milk, faeces, urine, and birth by-products. 
Especially the latter contain large numbers of bacteria which may become aerosolized after 
drying and remain virulent in the environment for months (Hartzell et al. 2008, Maurin et 
al. 1999, Parker et al. 2006). A recent Q fever outbreak in The Netherlands linked to dairy 
goat farms demonstrated the difficulties of controlling the disease in reservoir animals and 
the potential for large human outbreaks including fatalities associated with animal farming 
(Roest et al. 2010, Schimmer et al. 2010, van der Hoek et al. 2010). 
In Germany, Q fever is endemic in the Southern federal states of Hesse, Bavaria and 
Baden-Wuerttemberg, and outbreaks have occurred repeatedly in the past (Gilsdorf et al. 
2008, Hellenbrand et al. 2001, Lyytikainen et al. 1997, Lyytikainen et al. 1998, Porten et al. 
2006, Robert Koch-Institut 2008). Most of them were associated with exposure to sheep, 
whereas goat farming does not play a major role in Germany. 
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Although veterinarians are assumed to be at risk for Q fever due to their frequent exposure 
to animals, large scale studies and systematic risk factor analyses are absent in Europe. In 
two small descriptive studies from Denmark and Slovakia, 36% and 15% of tested 
veterinarians were seropositive for C. burnetii ( Bosnjak et al. 2010, Dorko et al. 2008), 
emphasizing the need for more in-depth analyses. 
We determined the serological status of veterinarians against C. burnetii and investigated 
factors associated with seropositivity to improve recommendations for early diagnosis of 
acute and chronic Q fever and prevention of chronic infections in this sub-population. 
 
Materials and Methods 
Data collection 
We conducted a seroepidemiological and occupational risk survey among attendants of the 
Bavarian Veterinarians Conference held in May 2009. Approximately 1,400 persons were 
expected to attend the conference. Attendants were mostly from the federal state of Bavaria 
(87%) and, to a lesser extent, from neighbouring Baden-Wuerttemberg (4%). They were 
eligible for participation in the cross-sectional study if they were ≥18 years old and 
provided written informed consent. From each participant we collected a blood sample in a 
10 mL serum separator tube and information on demographics, current field of 
occupational activity, exposures during the 12 months preceding the study, and use of 
personal protective equipment during work using a self-administered standardized 
questionnaire. Participants whose serological results indicated recent or chronic infection 
with C. burnetii (see Laboratory procedures), were asked to provide a follow-up serum 
sample taken by a general practitioner. 
Laboratory procedures 
Tubes were centrifuged on site and stored at -20°C until testing. Serum samples were 
screened for C. burnetii phase II IgG antibodies by an enzyme-linked immuno-sorbent 
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assay (ELISA, Virion/Serion). If screened positive (>30 U/ml) or borderline (20-30 U/ml), 
we performed a phase II IgM ELISA. Positive samples were confirmed and quantified by 
an immunofluorescence test (IFAT, BIOS/Focus, Cypress, CA) for phase I and phase II 
IgG (Wagner-Wiening et al. 2006). Samples with simultaneously high (≥1:512) phase II 
and phase I IgG antibody titres were considered to potentially have beginning or already 
existing chronic infection and were tested for C. burnetii by PCR assay (Fenollar et al. 
2007). 
Data analysis 
We compared seroprevalence in exposed and unexposed using the Chi-square test and 
calculated 95% confidence intervals for the prevalence ratio which we used as risk 
measure. All variables associated with seropositivity in univariable analyses (two-sided P 
values <0.2) were included in the initial multivariable logistic regression model and were 
then excluded in a stepwise backward selection procedure. Due to missing values for some 
of the covariates we applied the exclusion criterion of P>0.1 and subsequently of P>0.05. 
The final model (Model 1) was re-run including all participants with non-missing values on 
the final covariates. Based on these results we ran an additional analysis replacing the 
animal exposure variables in the final model with the following sub-variables for each 
animal group: monthly number of obstetrics performed, weekly number of individual 
animals treated, and weekly number of animal herds treated (Model 2). Again we applied 
the same model selection procedure as above. Age-group and sex were forced-in covariates 
in all models. We used Epidata (Odense, Denmark) for data entry and Stata (College 
Station, Texas, USA) for all analyses. 
The study was approved by the ethics committee of the Charité, University Medicine, 





In total, 424 of 1,400 expected conference attendants (30%) participated in the study, 276 
(65%) were female, 367 (87%) were from the federal state of Bavaria. Information on 
number and characteristics of non-responders was not available. Male participants were 
older than female participants (median age 48 vs. 37 years, p<0.0001, Wilcoxon rank-sum 
test). 
A total of 207 participants (49%) reported occupational exposure to cattle, 147 (35%) to 
sheep, 127 (30%) to birds (114 (27%) of these only to pet birds), 116 (27%) to horses, 110 
(26%) to pigs, 83 (20%) to goats and 276 (65%) to small animals (53 (13%) of these to 
small animals only). The matrix of reported exposure to cattle, sheep and goats is shown in 
Table 1. 
Of the participants with occupational exposure to cattle, sheep or goats, 70%, 58% and 
46% reported to perform obstetric activity on these animals, respectively. 
Serological results 
Sera of 162 (38%) participants had positive or borderline phase II IgG antibody titre 
results, including 18 (4%) participants with simultaneously elevated phase II IgG and IgM 
antibody concentrations indicating recent infection with C. burnetii. Phase II IgG antibody 
concentrations ranged from 20 to >500 U/ml (ELISA) and from ≥1:16 to ≥1:2048 (IFAT), 
phase I IgG from ≥1:16 to ≥1:1024 (IFAT). In 17 (4%) participants, chronic Q fever could 
not be excluded initially. PCR tests were negative in all 17. Of these, 16 provided a follow-
up serum 4 to 8 months after the initial sampling, 3 of which showed significantly 
decreasing antibody titres (twofold phase II and/or phase I IgG antibody endpoint decrease) 
indicating serological recovery. In the other 13 participants titres remained unchanged. 
Risk factor analyses 
In the univariable analyses we identified various exposures significantly associated with 
seropositivity (Table 2). Of the 20 variables included in the first multivariable logistic 
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regression model, the following were independently associated with seropositivity (Model 
1, Table 3): occupational exposure to cattle, occupational exposure to sheep, male sex, and 
increasing age. Looking at occupational exposure to cattle and sheep in more detail in the 
second logistic regression model (Model 2, Table 3), the adjusted odds ratio increased with 
increasing numbers of cattle obstetrics performed per month and with increasing numbers 
of individual cattle treated per week. 
 
Discussion 
In this cross-sectional study among German veterinarians we found an unexpectedly high 
C. burnetii antibody prevalence implying a high lifetime risk of Q fever for this 
occupational group. The seroprevalence we found is considerably higher than the 0-18% 
derived from a small study among the general population in Baden-Wuerttemberg, the 
federal state neighboring Bavaria (Brockmann et al., in preparation). It is also higher than 
the 13-22% found in studies among veterinarians in the United States, Australia, Japan and 
Slovakia (Abe et al. 2001, Casolin1999, Dorko et al. 2008, Whitney et al. 2009) but 
comparable to the 36% found in Denmark (Bosnjak et al. 2010). Whether the high 
seroprevalence correlates with a high disease burden cannot be explained by our study. 
In our analyses, the variables for occupational exposure to cattle were the best predictors 
for seropositivity, followed by occupational exposure to sheep which was also associated 
with seropositivity in a recent US study (Whitney et al. 2009). To our knowledge this is the 
first time that an association between cattle obstetrics and C. burnetii seropositivity has 
been established through an analytical study. Our cross-sectional study design does not 
allow us to determine whether the exposures preceded the outcome and thus to evaluate 
causality. However, the strength of the association, the positive dose-response relationship, 
the biological plausibility and the analogy with birth products of small ruminants being a 
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source of infection with C. burnetii for humans argues for a causal relationship between 
performing cattle obstetrics and seropositivity. 
In order to limit recall bias we only acquired information on exposures during the 12 
months preceding the study. Exposures prior to this time period, e.g. to sheep or goats, may 
have confounded the association between exposure to cattle and seropositivity. However, 
from our data we have no evidence that this was the case in our study population. 
The impact of an animal species on the transmission of Q fever to humans presumably 
depends on the main types of exposure to an animal species in a population and the 
infection rate of these animals. Whereas in The Netherlands extensive goat farming has 
contributed to one of the biggest Q fever outbreaks in history, in Germany cattle farming is 
the predominant type of animal farming. The number of cattle on farms was 12.6 millions 
in 2010, compared to 2.2 million sheep and 124,200 goats (Federal Statistical Office 2010). 
A recent survey among cattle in Bavaria found a seroprevalence of 15% and a herd 
prevalence of 72% of C. burnetii antibodies (Böttcher et al. 2011) indicating a wide spread 
of infection among animals offering a wide source of exposure for veterinarians. 
Our study population was a convenience sample of veterinarians and may not be entirely 
representative of veterinarians in Bavaria or in Germany. Although veterinarians in 
Germany are represented in terms of distribution of age, sex, and types of animal practices 
according to official statistics (Federal Association of Veterinarians 2010), differences in 
infection rates of the different animal species between regions may lead to differences in 
seroprevalence. 
C. burnetii is considered a class 3 biological agent, and regulations exist regarding 
protective measures for activities involving biological agents in agriculture (Federal 
Institute for Occupational Safety and Health 2004). Accordingly, Q fever is recognized as 
an occupational disease in Germany (Federal Act on Occupational Diseases 2009), 
however, to our knowledge the topic of occupational health and safety is not included in 
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the curriculum of veterinary faculties in Germany. In addition to increased efforts on 
informing veterinarians and veterinarian apprentices about Q fever and potential sources of 
infection, education on the use of personal protective equipment and a safe vaccination 
would be desirable. A whole-cell vaccine licensed in Australia for the use in risk groups 
shows >80% efficacy against clinical disease but increased reactogenity in previously 
seropositive subjects (Chiu et al. 2007, Zhang et al. 2004). This vaccine is not licensed in 
Europe to date, but licensure for specific risk groups could be considered. 
 
Conclusions 
We recommend that awareness should be raised among veterinarians at an early point in 
their career about the clinical picture of Q fever and about cattle as potential sources of 
infection with C. burnetii, in addition to small ruminants which are often in the focus of 
public attention regarding Q fever. Education on occupational health and safety should be 
an obligatory component of the curriculum of veterinary faculties in Germany. 
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Table 1: Distribution of occupational exposure to cattle, sheep, and goats, among study 
participants. Cross-sectional study among veterinarians, Bavaria, 2009. 
NO YES Total NO YES Total
NO 200 1 201 72 4 76
YES 10 6 16 59 72 131
Total 210 7 217 131 76 207





Table 2: Results of the univariable risk factor analysis. Cross-sectional study among 
veterinarians, Bavaria, 2009. PR= prevalence ratio, CI=confidence interval, significant results 
(P<.05) bold, *=variable included in initial multivariable model. 
 
Animal exposures
Any exposure to cattle 218 116 53 206 46 22 2,38 1.79-3.16 0,000
- Occupational 207 115 56 217 47 22 2,57 1.94-3.40 0.000*
-- Cattle obstetrics 145 94 65 279 68 24 2,66 2.09-3.38 0,000
-- Treating individual cattle 184 109 59 235 52 22 2,68 2.05-3.50 0,000
-- Treating cattle herds 178 104 58 239 57 24 2,45 1.89-3.17 0,000
- Non-occupational 38 11 29 383 151 39 0,73 0.44-1.23 0,205
Any exposure to sheep 153 89 58 271 73 27 2,16 1.70-2.74 0,000
- Occupational 147 89 61 277 73 26 2,3 1.81-2.91 0.000*
-- Sheep obstetrics 85 61 72 339 101 30 2,41 1.95-2.97 0,000
-- Treating individual sheep 109 69 63 310 92 30 2,13 1.71-2.67 0,000
-- Treating sheep flocks 92 54 59 325 107 33 1,78 1.41-2.25 0,000
- Non-occupational 23 7 30 398 155 39 0,78 0.42-1.47 0,415
Any exposure to goats 90 53 59 334 109 33 1,80 1.43-2.27 0,000
- Occupational 83 52 63 341 110 32 1,94 1.55-2.44 0.000*
-- Goat obstetrics 38 28 74 386 134 35 2,12 1.68-2.68 0,000
-- Treating individual goats 5 1 20 419 161 38 0,52 0.09-3.02 0,399
-- Treating goat f locks 58 33 57 359 128 36 1,60 1.23-2.08 0,002
- Non-occupational 14 5 36 407 157 39 0,93 0.45-1.89 0,829
Any exposure to pigs 121 66 55 303 96 32 1,72 1.37-2.17 0,000
- Occupational 110 62 56 314 100 32 1,77 1.41-2.23 0.000*
-- Pig obstetrics 58 31 53 366 131 36 1,49 1.13-1.97 0,010
-- Treating individual pigs 20 7 35 404 155 38 0,91 0.50-1.68 0,762
-- Treating pig herds 101 57 56 316 104 33 1,71 1.36-2.16 0,000
- Non-occupational 18 6 33 403 156 39 0,86 0.44-1.67 0,646
Any exposure to horses 191 79 41 233 83 36 1,16 0.91-1.48 0,226
- Occupational 116 59 51 308 103 33 1,52 1.20-1.93 0.001*
-- Horse obstetrics 38 22 58 386 140 36 1,60 1.18-2.16 0,009
-- Treating individual horses 109 57 52 310 104 34 1,56 1.23-1.98 0,001
-- Treating horse herds 16 7 44 408 155 38 1,15 0.65-2.03 0,642
- Non-occupational 164 51 31,1 257 111 43,19 0,72 0.55-0.94 0.013*
Any exposure to birds 152 51 34 272 111 41 0,82 0.63-1.07 0,140
- Occupational 127 44 35 297 118 40 0,87 0.66-1.15 0,324
-- Treating individual birds 118 41 35 300 120 40 0,87 0.65-1.15 0,320
-- Treating poultry f locks 13 5 38 411 157 38 1,01 0.50-2.02 0,985
- Non-occupational 47 12 26 374 150 40 0,64 0.38-1.05 0.053*
Any exposure to dogs 361 133 37 63 29 46 0,80 0.59-1.08 0,166
- Occupational 259 93 36 160 68 43 0,84 0.66-1.08 0.178*
- Non-occupational 276 100 36 145 62 43 0,85 0.66-1.08 0.191*
Any exposure to cats 343 129 38 81 33 41 0,92 0.69-1.24 0,602
- Occupational 254 95 37 165 66 40 0,94 0.73-1.20 0,593
- Non-occupational 270 99 37 151 63 42 0,88 0.69-1.12 0,307
Any exposure to small animals 205 65 32 219 97 44 0,72 0.56-0.92 0,008
- Occupational 168 49 29 251 112 45 0,65 0.50-0.86 0.001*
- Non-occupational 65 21 32 356 141 40 0,82 0.56-1.19 0,266
Exposure to Q fever infected animal 24 18 75 346 127 37 2,04 1.56-2.67 0.000*
Animal bite 312 118 38 103 42 41 0,93 0.71-1.22 0,593
Needlestick injury during w ork 290 126 43 122 32 26 1,66 1.20-2.29 0.001*
Male sex 146 81 55 276 81 29 1,89 1.50-2.39 0.000*
Age group [years]
<30 64 7 11 Ref. *
30-39 138 54 39 64 7 11 3,58 1.73-7.42 0,000
40-49 118 48 41 64 7 11 3,72 1.79-7.74 0,000
≥50 102 53 52 64 7 11 4,75 2.30-9.80 0,000
Use of personal protective equipment
Hand disinfection after
- exposure to potentially infectious agents 312 119 38 71 36 51 0,75 0.57-0.98 0.052*
 - general exposure to patients 139 50 36 239 102 43 0,84 0.65-1.10 0,200
Washing hands after
- exposure to potentially infectious agents 384 150 39 4 3 75 0,52 0.29-0.93 0.143*
- general exposure to patients 354 143 40 31 10 32 1,25 0.74-2.12 0,375
Wearing gloves during general exposure to patients 73 35 48 315 118 37 1,28 0.97-1.69 0.099*
Wearing face mask during general exposure to patients 4 2 50 381 150 39 1,27 0.47-3.41 0,665
Dietary exposures
Wild boar liver 25 9 36 379 146 39 0,93 0.55-1.60 0,802
Wild boar meat 152 62 41 237 87 37 1,11 0.86-1.43 0,419
Pig liver 100 41 41 306 115 38 1,09 0.83-1.44 0,542
Pork 143 60 42 267 98 37 1,14 0.89-1.47 0,298
Venison 193 84 44 189 65 34 1,27 0.98-1.63 0.067*
Raw  milk 180 62 34 229 98 43 0,80 0.63-1.03 0.086*
Offals 125 55 44 259 91 35 1,25 0.97-1.62 0.094*
Leisure time activities
Hunting 28 13 46 381 142 37 1,25 0.82-1.89 0,335
Water sports 342 129 38 82 33 40 0,94 0.70-1.26 0,673
Playing golf 9 4 44 400 151 38 1,18 0.56-2.47 0,682
Gardening 243 92 38 166 63 38 1,00 0.77-1.28 0,985
Walking in the w oods 341 128 38 68 27 40 0,95 0.68-1.31 0,736







Table: Results of the univariable risk factor analysis. Cross-sectional study among veterinarians, Bavaria, 2009. PR= prevalence ratio, CI=confidence interval, 















Table 3: Results of the final logistic regression models of the multivariable risk factor 
analysis. In model 2 the variables for occupational exposure to cattle and sheep were replaced 
with the following three sub-variables, respectively: weekly number of individual cattle/sheep 
treated, monthly number of cattle/sheep obstetrics procedures performed, and weekly number 
of cattle herds/sheep flocks treated. n/i=variable removed from multivariable model during 
model selection process and therefore not included in the final model, aOR=adjusted odds 
ratio, CI=confidence interval. 
Exposure variable aOR 95%CI P aOR 95%CI P
Occupational exposure to cattle 2.83 1.64-4.87 <0.001
-  Weekly number of individual cattle treated 1.01 1.00-1.02 0.005
- Monthly number of cattle obstetrics performed 1.13 1.04-1.22 0.003
- Weekly number of cattle herds treated
Occupational exposure to sheep 2.09 1.22-3.58 0.007
-  Weekly number of individual sheep treated
- Monthly number of sheep obstetrics performed
- Weekly number of sheep flocks treated
Male sex 1.90 1.15-3.13 0.012 1.71 1.01-2.89 0.044
Age group [years]
<30 Ref.
30-39 4.91 2.00-12.04 0.001 4.59 1.83-11.51 0.001
40-49 5.32 2.12-13.33 <0.001 4.98 1.95-12.71 0.001
≥50 6.70 2.60-17.25 <0.001 4.64 1.76-12.25 0.002
n/i
Model 1 (n=421) Model 2 (n=400)
n/i
n/i
n/i
 
